Skip to main content

Big Pharma gravy train hits the skids under Trump, panicking revolving-door regulators, investors

 The article discusses recent changes in the U. S. regulatory environment under the Trump administration, focusing on the Food and Drug Administration (FDA) and its relationship with the pharmaceutical industry. It highlights the implications of job cuts and leadership changes on drug approval processes and public health.

1. The Trump administration is undergoing significant changes in the public health workforce, leading to fears within the pharmaceutical industry about the future of drug approvals.

2. A notable departure is that of FDA's Peter Marks, whose exit has caused drug stock prices to drop and raised concerns about the FDA's future role in regulating drug safety and efficacy.

3. The Department of Health and Human Services (HHS) announced cuts to its workforce, including substantial job losses at the NIH, which has prompted further changes in health research priorities.

4. Many former regulators express concern that these changes will slow down drug discovery and approval, potentially causing delays for patients needing treatments, especially in the area of rare diseases.

5. Critics argue that the FDA has historically favored the pharmaceutical industry's interests over patient safety, and previous management allowed less rigorous studies for approvals.

6. There's contention regarding the effectiveness of COVID boosters authorized under Marks' leadership, with some researchers criticizing these decisions lacking solid scientific backing.

7. The reduction of federal funding and structural changes at key health agencies may impact scientific progress and discourage development of innovative therapies like gene therapies and mRNA vaccines.

The ongoing upheaval within the FDA and HHS raises significant concerns over the effectiveness and priorities of U. S. drug regulation. With a history of collaboration between regulators and the pharmaceutical industry, the current shifts could lead to a reevaluation of drug approval processes and raise questions about future public health outcomes. 

https://justthenews.com/government/federal-agencies/big-pharma-gravy-train-hits-skids-under-trump-panicking-revolving-door

Comments

Popular posts from this blog

Fauci Files Reveal Pfizer Helped Biden Rig 2020 Election

 Pfizer secretly colluded with Joe Biden's team to help him rig the 2020 election against Trump, according to new Fauci documents. In his new book, "On Call," Fauci admits that Albert Bourla, the CEO of Pfizer, called him the night after Biden was declared the winner of the election, to inform him of Pfizer's "Game-changing results" from the rigged mRNA trial. "On November 7, after the absentee ballots were counted, Joe Biden was declared the winner of the presidential election. It was the very next night that Albert Bourla, Pfizer's CEO, called me away from my neighbors' fire pit to inform me about the game-changing results from the Pfizer mRNA vaccine trial. I finally thought we had truly turned a corner in defeating this terrible disease." Today reports: In another interesting tidbit, Fauci discusses Trump's FDA Commissioner Stephen Hahn declaring that he would not go along with the Trump Administration's plan to roll out the vac...

FDA & U.S. Postal Service Linked to Black Market Abortion Pill Cartels.

 Mexico-based drug cartels facilitating an increase in unauthorized, self-conducted abortions in the United States continue unimpeded partly due to insufficient regulation by the Food and Drug Administration and the United States Postal Service, according to a report by the American Life League. Katie Brown, ALL's national director, criticizes the FDA and USPS for failing to adequately regulate the distribution and screening of abortion-inducing drugs like Mifepristone and Misoprostol. Subscribe here The report, titled Beneath the Surface: Exposing the Abortion Pill Drug Cartel, highlights the operations of Las Libres, a Mexico-based organization that advocates for universal abortion access. It promotes the distribution of abortion pills through online networks, reaching women and girls across the U.S., often sending the drugs via USPS. RISKS. ALL emphasizes that these pills frequently come from unregulated sources, heightening the risks of additional harmful substances being prese...

James Ray Epps Breaks Federal Law Lying To FBI Agents, Again, In Never Before Released Leaked Audio: ‘You Are The Boss’

 The Gateway Pundit has obtained more leaked audio of James Ray Epps' providing materially false statements during an abnormally friendly interview with the Federal Bureau of Investigations about his role in the Capitol riot, a crime punishable by up to eight years in prison. Joined by his attorney John Blischak, a former FBI agent, and his wife Robyn Epps during a voluntary March 3, 2021 interview, Epps assured the feds while laughing and cracking jokes that he only traveled from Arizona to Washington, DC to protect his son James Ray Epps Jry and "Try to deescalate" a "Raging" crowd amid a terrorist attack he suspected would transpire involving a bomb. On the 8th, Epps insisted at least fourteen times that he only traveled to DC to "Try to calm them down." Conspicuously, in thousands of hours of January 6 footage, Epps is never seen with his son. Epps claimed Baked Alaska, who served 60 days in prison for protesting at the Capitol, was to blame for in...